Annual Book Value
$266.32 M
+$260.40 M+176.36%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual book value is currently $266.32 million, with the most recent change of +$260.40 million (+176.36%) on 31 December 2023. During the last 3 years, it has risen by +$247.78 million (+1336.40%). EYPT annual book value is now at all-time high.EYPT Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$218.73 M
-$9.57 M-4.19%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly book value is currently $218.73 million, with the most recent change of -$9.57 million (-4.19%) on 30 September 2024. Over the past year, it has increased by +$160.11 million (+273.13%). EYPT quarterly book value is now -17.87% below its all-time high of $266.32 million, reached on 31 December 2023.EYPT Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +176.4% | +273.1% |
| 3 y3 years | +1336.4% | +135.8% |
| 5 y5 years | +607.7% | +1272.4% |
EYPT Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1336.4% | -17.9% | +282.0% |
| 5 y | 5 years | at high | +3097.2% | -17.9% | +5122.9% |
| alltime | all time | at high | +6404.1% | -17.9% | +5241.9% |
EyePoint Pharmaceuticals Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $218.73 M(-4.2%) |
| June 2024 | - | $228.31 M(-8.7%) |
| Mar 2024 | - | $249.93 M(-6.2%) |
| Dec 2023 | $266.32 M(+176.4%) | $266.32 M(+354.3%) |
| Sept 2023 | - | $58.62 M(+2.4%) |
| June 2023 | - | $57.26 M(-27.0%) |
| Mar 2023 | - | $78.39 M(-18.7%) |
| Dec 2022 | $96.37 M(-47.7%) | $96.37 M(-29.3%) |
| Sept 2022 | - | $136.35 M(-9.9%) |
| June 2022 | - | $151.37 M(-9.3%) |
| Mar 2022 | - | $166.82 M(-9.5%) |
| Dec 2021 | $184.38 M(+894.4%) | $184.38 M(+98.8%) |
| Sept 2021 | - | $92.75 M(-13.2%) |
| June 2021 | - | $106.86 M(-7.6%) |
| Mar 2021 | - | $115.71 M(+524.1%) |
| Dec 2020 | $18.54 M(+122.6%) | $18.54 M(+144.2%) |
| Sept 2020 | - | $7.59 M(+81.3%) |
| June 2020 | - | $4.19 M(-74.6%) |
| Mar 2020 | - | $16.47 M(+97.8%) |
| Dec 2019 | $8.33 M(-77.9%) | $8.33 M(-47.7%) |
| Sept 2019 | - | $15.94 M(-43.5%) |
| June 2019 | - | $28.21 M(+41.9%) |
| Mar 2019 | - | $19.88 M(-58.3%) |
| Dec 2018 | $37.63 M(+222.0%) | - |
| Sept 2018 | - | $47.70 M(+308.2%) |
| June 2018 | $11.69 M(-12.4%) | $11.69 M(+42.6%) |
| Mar 2018 | - | $8.20 M(-17.2%) |
| Dec 2017 | - | $9.90 M(+10.0%) |
| Sept 2017 | - | $9.00 M(-32.5%) |
| June 2017 | $13.34 M(-36.1%) | $13.34 M(+6.6%) |
| Mar 2017 | - | $12.51 M(-15.3%) |
| Dec 2016 | - | $14.76 M(+2.2%) |
| Sept 2016 | - | $14.45 M(-30.8%) |
| June 2016 | $20.88 M(-10.6%) | $20.88 M(-21.4%) |
| Mar 2016 | - | $26.55 M(+84.1%) |
| Dec 2015 | - | $14.42 M(-23.4%) |
| Sept 2015 | - | $18.82 M(-19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $23.37 M(+56.6%) | $23.37 M(-16.1%) |
| Mar 2015 | - | $27.85 M(-13.7%) |
| Dec 2014 | - | $32.27 M(-9.9%) |
| Sept 2014 | - | $35.80 M(+139.9%) |
| June 2014 | $14.92 M(+93.8%) | $14.92 M(-18.7%) |
| Mar 2014 | - | $18.35 M(+45.6%) |
| Dec 2013 | - | $12.60 M(-11.5%) |
| Sept 2013 | - | $14.24 M(+84.9%) |
| June 2013 | $7.70 M(-43.5%) | $7.70 M(-31.5%) |
| Mar 2013 | - | $11.24 M(-18.6%) |
| Dec 2012 | - | $13.81 M(-14.6%) |
| Sept 2012 | - | $16.16 M(+18.5%) |
| June 2012 | $13.64 M(-63.6%) | $13.64 M(-12.3%) |
| Mar 2012 | - | $15.55 M(-12.6%) |
| Dec 2011 | - | $17.79 M(-49.5%) |
| Sept 2011 | - | $35.23 M(-5.9%) |
| June 2011 | $37.43 M(+13.3%) | $37.43 M(+1.2%) |
| Mar 2011 | - | $36.99 M(+18.9%) |
| Sept 2010 | - | $31.11 M(-5.9%) |
| June 2010 | $33.04 M(+40.4%) | $33.04 M(+68.8%) |
| Mar 2010 | - | $19.58 M(-12.9%) |
| Dec 2009 | - | $22.48 M(+4.2%) |
| Sept 2009 | - | $21.57 M(-8.4%) |
| June 2009 | $23.54 M(-21.7%) | $23.54 M(+11.6%) |
| Mar 2009 | - | $21.09 M(-3.2%) |
| Dec 2008 | - | $21.79 M(-20.2%) |
| Sept 2008 | - | $27.32 M(-9.2%) |
| June 2008 | $30.08 M(-64.0%) | $30.08 M(-66.3%) |
| Mar 2008 | - | $89.16 M(-5.8%) |
| Dec 2007 | - | $94.67 M(-6.7%) |
| Sept 2007 | - | $101.50 M(+21.5%) |
| June 2007 | $83.55 M(-35.7%) | $83.55 M(+26.2%) |
| Dec 2006 | - | $66.20 M(-49.1%) |
| June 2006 | $129.96 M(+114.7%) | $129.96 M(+114.7%) |
| June 2005 | $60.52 M(+136.4%) | $60.52 M(+136.4%) |
| June 2004 | $25.60 M(+525.3%) | $25.60 M(+525.3%) |
| June 2003 | $4.09 M(-10.5%) | $4.09 M |
| June 2001 | $4.57 M | - |
FAQ
- What is EyePoint Pharmaceuticals annual book value?
- What is the all time high annual book value for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual book value year-on-year change?
- What is EyePoint Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly book value year-on-year change?
What is EyePoint Pharmaceuticals annual book value?
The current annual book value of EYPT is $266.32 M
What is the all time high annual book value for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual book value is $266.32 M
What is EyePoint Pharmaceuticals annual book value year-on-year change?
Over the past year, EYPT annual book value has changed by +$169.96 M (+176.36%)
What is EyePoint Pharmaceuticals quarterly book value?
The current quarterly book value of EYPT is $218.73 M
What is the all time high quarterly book value for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly book value is $266.32 M
What is EyePoint Pharmaceuticals quarterly book value year-on-year change?
Over the past year, EYPT quarterly book value has changed by +$160.11 M (+273.13%)